Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07322679Not ApplicableNot Yet Recruiting

Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults

Role: lead

NCT07267845Not ApplicableRecruiting

The Effect of α-GPC on Cognitive Function and Sports Performance

Role: lead

NCT07210684Not ApplicableRecruiting

Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes

Role: lead

All 3 trials loaded